Dexamethasone sodium phosphate (AVM Biotechnology)

地塞米松磷酸酯 (AVM Biotechnology)

Report date: 2024/08/21 17:13:19

Base Information

Drug NameDexamethasone sodium phosphate (AVM Biotechnology)

Drug Alias NameSupra-Pharmacologic Dexamethasone sodium phosphate (AVM Biotechnology)Supra-Pharmacologic Dexamethasone Phosphate (AVM Biotechnology)AVM-0703AVM0703

ClassificationSmall molecules > Steroids

Mechanisms of ActionGlucocorticoid receptor agonists

TargetsGlucocorticoid receptor

Therapy Area/IndicationsLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAvm Biotechnology Llc

China Registration ClassN/A

Develop Information

Active CompaniesAVM Biotechnology Inc

Inactive CompaniesN/A

Active IndicationsLymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A